Preliminary clinical assessment of dynamic carbon-11 methionine positron-emission tomography/computed tomography for the diagnosis of the pathologies in patients with musculoskeletal lesions: a prospective study

Background This study prospectively assessed the diagnostic capacity of dynamic carbon-11 methionine (C-11 MET) positron-emission tomography (PET)/computed tomography for the diagnosis of pathologies in patients with primary unknown musculoskeletal lesions (MSLs). In total, 13 patients with MSLs und...

Full description

Saved in:
Bibliographic Details
Published inEJNMMI reports Vol. 4; no. 1; pp. 15 - 13
Main Authors Shinya, Takayoshi, Otomi, Yoichi, Nishisho, Toshihiko, Beuthien-Baumann, Bettina, Kubo, Michiko, Otsuka, Hideki, Bando, Yoshimi, Yanagawa, Hiroaki, Sairyo, Koichi, Harada, Masafumi
Format Journal Article
LanguageEnglish
Published Cham Springer International Publishing 26.08.2020
Springer Nature B.V
SpringerOpen
Subjects
C-11 MET
Carbon
Computed tomography
Diagnosis
Diagnostic systems
Diagnostic validity
Dynamic PET/CT
Emission analysis
Imaging
Lesions
Lymphoma
Malignant lymphoma
Medical diagnosis
Medicine
Medicine & Public Health
Metastases
Methionine
Musculoskeletal lesion
Nuclear Medicine
Original
Original Article
Phases
Positron emission
Positron emission tomography
Radiology
Sarcoma
Tomography
Tumors
C-11 MET
Sarcoma
Diagnostic validity
SUVmax
Malignant lymphoma
Musculoskeletal lesion
Dynamic PET/CT
Online AccessGet full text
ISSN2510-3636
2510-3636
3005-074X
DOI10.1186/s41824-020-00083-x

Cover

Abstract Background This study prospectively assessed the diagnostic capacity of dynamic carbon-11 methionine (C-11 MET) positron-emission tomography (PET)/computed tomography for the diagnosis of pathologies in patients with primary unknown musculoskeletal lesions (MSLs). In total, 13 patients with MSLs underwent dynamic scans (5–10 [phase 1], 10–15 [phase 2], 15–20 [phase 3], 20–25 [phase 4], 25–30 [phase 5], and 30–35 [phase 6] min post-injection of C-11 MET). We statistically compared the maximum standardised uptake values (SUVmax) and corresponding retention index for dynamic scans (RI-SUV) for five benign MSLs (BMSLs), five primary malignant musculoskeletal tumours (PMMSTs), four metastatic musculoskeletal tumours (MMSTs), and three malignant lymphoma (ML) cases and explored their diagnostic capacities using receiver operating characteristic (ROC) curve analyses. Results SUVmax gradually decreased or remained similar with minimal fluctuations in all BMSL cases and four of five PMMST cases. In contrast, SUVmax increased over time in one case of PMMST and in all cases of MMST and ML. Significant differences were observed in SUVmax for all time phases and RI-SUV between BMSLs and MMSLs, in SUVmax for all time phases between PMMSTs and BMSLs, in SUVmax for all time phases and RI-SUV between non-PMMST-malignant tumours and BMSL, and in RI-SUV between non-PMMST-malignant tumours and PMMST. In ROC analyses, the areas under the curve yielded the highest values at 1.00 for differentiating most intergroup comparisons. Conclusions Dynamic C-11 MET PET scans have the potential to be good predictors of discriminating MSLs in patients with primary unknown MSLs in clinical practice.
AbstractList This study prospectively assessed the diagnostic capacity of dynamic carbon-11 methionine (C-11 MET) positron-emission tomography (PET)/computed tomography for the diagnosis of pathologies in patients with primary unknown musculoskeletal lesions (MSLs). In total, 13 patients with MSLs underwent dynamic scans (5-10 [phase 1], 10-15 [phase 2], 15-20 [phase 3], 20-25 [phase 4], 25-30 [phase 5], and 30-35 [phase 6] min post-injection of C-11 MET). We statistically compared the maximum standardised uptake values (SUVmax) and corresponding retention index for dynamic scans (RI-SUV) for five benign MSLs (BMSLs), five primary malignant musculoskeletal tumours (PMMSTs), four metastatic musculoskeletal tumours (MMSTs), and three malignant lymphoma (ML) cases and explored their diagnostic capacities using receiver operating characteristic (ROC) curve analyses.BACKGROUNDThis study prospectively assessed the diagnostic capacity of dynamic carbon-11 methionine (C-11 MET) positron-emission tomography (PET)/computed tomography for the diagnosis of pathologies in patients with primary unknown musculoskeletal lesions (MSLs). In total, 13 patients with MSLs underwent dynamic scans (5-10 [phase 1], 10-15 [phase 2], 15-20 [phase 3], 20-25 [phase 4], 25-30 [phase 5], and 30-35 [phase 6] min post-injection of C-11 MET). We statistically compared the maximum standardised uptake values (SUVmax) and corresponding retention index for dynamic scans (RI-SUV) for five benign MSLs (BMSLs), five primary malignant musculoskeletal tumours (PMMSTs), four metastatic musculoskeletal tumours (MMSTs), and three malignant lymphoma (ML) cases and explored their diagnostic capacities using receiver operating characteristic (ROC) curve analyses.SUVmax gradually decreased or remained similar with minimal fluctuations in all BMSL cases and four of five PMMST cases. In contrast, SUVmax increased over time in one case of PMMST and in all cases of MMST and ML. Significant differences were observed in SUVmax for all time phases and RI-SUV between BMSLs and MMSLs, in SUVmax for all time phases between PMMSTs and BMSLs, in SUVmax for all time phases and RI-SUV between non-PMMST-malignant tumours and BMSL, and in RI-SUV between non-PMMST-malignant tumours and PMMST. In ROC analyses, the areas under the curve yielded the highest values at 1.00 for differentiating most intergroup comparisons.RESULTSSUVmax gradually decreased or remained similar with minimal fluctuations in all BMSL cases and four of five PMMST cases. In contrast, SUVmax increased over time in one case of PMMST and in all cases of MMST and ML. Significant differences were observed in SUVmax for all time phases and RI-SUV between BMSLs and MMSLs, in SUVmax for all time phases between PMMSTs and BMSLs, in SUVmax for all time phases and RI-SUV between non-PMMST-malignant tumours and BMSL, and in RI-SUV between non-PMMST-malignant tumours and PMMST. In ROC analyses, the areas under the curve yielded the highest values at 1.00 for differentiating most intergroup comparisons.Dynamic C-11 MET PET scans have the potential to be good predictors of discriminating MSLs in patients with primary unknown MSLs in clinical practice.CONCLUSIONSDynamic C-11 MET PET scans have the potential to be good predictors of discriminating MSLs in patients with primary unknown MSLs in clinical practice.
Abstract Background This study prospectively assessed the diagnostic capacity of dynamic carbon-11 methionine (C-11 MET) positron-emission tomography (PET)/computed tomography for the diagnosis of pathologies in patients with primary unknown musculoskeletal lesions (MSLs). In total, 13 patients with MSLs underwent dynamic scans (5–10 [phase 1], 10–15 [phase 2], 15–20 [phase 3], 20–25 [phase 4], 25–30 [phase 5], and 30–35 [phase 6] min post-injection of C-11 MET). We statistically compared the maximum standardised uptake values (SUVmax) and corresponding retention index for dynamic scans (RI-SUV) for five benign MSLs (BMSLs), five primary malignant musculoskeletal tumours (PMMSTs), four metastatic musculoskeletal tumours (MMSTs), and three malignant lymphoma (ML) cases and explored their diagnostic capacities using receiver operating characteristic (ROC) curve analyses. Results SUVmax gradually decreased or remained similar with minimal fluctuations in all BMSL cases and four of five PMMST cases. In contrast, SUVmax increased over time in one case of PMMST and in all cases of MMST and ML. Significant differences were observed in SUVmax for all time phases and RI-SUV between BMSLs and MMSLs, in SUVmax for all time phases between PMMSTs and BMSLs, in SUVmax for all time phases and RI-SUV between non-PMMST-malignant tumours and BMSL, and in RI-SUV between non-PMMST-malignant tumours and PMMST. In ROC analyses, the areas under the curve yielded the highest values at 1.00 for differentiating most intergroup comparisons. Conclusions Dynamic C-11 MET PET scans have the potential to be good predictors of discriminating MSLs in patients with primary unknown MSLs in clinical practice.
Background This study prospectively assessed the diagnostic capacity of dynamic carbon-11 methionine (C-11 MET) positron-emission tomography (PET)/computed tomography for the diagnosis of pathologies in patients with primary unknown musculoskeletal lesions (MSLs). In total, 13 patients with MSLs underwent dynamic scans (5–10 [phase 1], 10–15 [phase 2], 15–20 [phase 3], 20–25 [phase 4], 25–30 [phase 5], and 30–35 [phase 6] min post-injection of C-11 MET). We statistically compared the maximum standardised uptake values (SUVmax) and corresponding retention index for dynamic scans (RI-SUV) for five benign MSLs (BMSLs), five primary malignant musculoskeletal tumours (PMMSTs), four metastatic musculoskeletal tumours (MMSTs), and three malignant lymphoma (ML) cases and explored their diagnostic capacities using receiver operating characteristic (ROC) curve analyses. Results SUVmax gradually decreased or remained similar with minimal fluctuations in all BMSL cases and four of five PMMST cases. In contrast, SUVmax increased over time in one case of PMMST and in all cases of MMST and ML. Significant differences were observed in SUVmax for all time phases and RI-SUV between BMSLs and MMSLs, in SUVmax for all time phases between PMMSTs and BMSLs, in SUVmax for all time phases and RI-SUV between non-PMMST-malignant tumours and BMSL, and in RI-SUV between non-PMMST-malignant tumours and PMMST. In ROC analyses, the areas under the curve yielded the highest values at 1.00 for differentiating most intergroup comparisons. Conclusions Dynamic C-11 MET PET scans have the potential to be good predictors of discriminating MSLs in patients with primary unknown MSLs in clinical practice.
BackgroundThis study prospectively assessed the diagnostic capacity of dynamic carbon-11 methionine (C-11 MET) positron-emission tomography (PET)/computed tomography for the diagnosis of pathologies in patients with primary unknown musculoskeletal lesions (MSLs). In total, 13 patients with MSLs underwent dynamic scans (5–10 [phase 1], 10–15 [phase 2], 15–20 [phase 3], 20–25 [phase 4], 25–30 [phase 5], and 30–35 [phase 6] min post-injection of C-11 MET). We statistically compared the maximum standardised uptake values (SUVmax) and corresponding retention index for dynamic scans (RI-SUV) for five benign MSLs (BMSLs), five primary malignant musculoskeletal tumours (PMMSTs), four metastatic musculoskeletal tumours (MMSTs), and three malignant lymphoma (ML) cases and explored their diagnostic capacities using receiver operating characteristic (ROC) curve analyses.ResultsSUVmax gradually decreased or remained similar with minimal fluctuations in all BMSL cases and four of five PMMST cases. In contrast, SUVmax increased over time in one case of PMMST and in all cases of MMST and ML. Significant differences were observed in SUVmax for all time phases and RI-SUV between BMSLs and MMSLs, in SUVmax for all time phases between PMMSTs and BMSLs, in SUVmax for all time phases and RI-SUV between non-PMMST-malignant tumours and BMSL, and in RI-SUV between non-PMMST-malignant tumours and PMMST. In ROC analyses, the areas under the curve yielded the highest values at 1.00 for differentiating most intergroup comparisons.ConclusionsDynamic C-11 MET PET scans have the potential to be good predictors of discriminating MSLs in patients with primary unknown MSLs in clinical practice.
ArticleNumber 15
Author Beuthien-Baumann, Bettina
Kubo, Michiko
Yanagawa, Hiroaki
Harada, Masafumi
Otsuka, Hideki
Bando, Yoshimi
Sairyo, Koichi
Shinya, Takayoshi
Nishisho, Toshihiko
Otomi, Yoichi
Author_xml – sequence: 1
  givenname: Takayoshi
  orcidid: 0000-0001-7101-5769
  surname: Shinya
  fullname: Shinya, Takayoshi
  email: midnight-2005@nifty.com
  organization: Department of Radiology, Tokushima University Hospital, Division of Radiology, German Cancer Research Centre (DKFZ), Department of Diagnostic and Therapeutic Radiology, Kawasaki Medical School General Medical Centre
– sequence: 2
  givenname: Yoichi
  surname: Otomi
  fullname: Otomi, Yoichi
  organization: Department of Radiology, Tokushima University Hospital
– sequence: 3
  givenname: Toshihiko
  surname: Nishisho
  fullname: Nishisho, Toshihiko
  organization: Department of Orthopedics, Institute of Biomedical Sciences, Tokushima University Graduate School
– sequence: 4
  givenname: Bettina
  surname: Beuthien-Baumann
  fullname: Beuthien-Baumann, Bettina
  organization: Division of Radiology, German Cancer Research Centre (DKFZ)
– sequence: 5
  givenname: Michiko
  surname: Kubo
  fullname: Kubo, Michiko
  organization: Department of Radiology, Tokushima University Hospital
– sequence: 6
  givenname: Hideki
  surname: Otsuka
  fullname: Otsuka, Hideki
  organization: Department of Medical Imaging/Nuclear Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School
– sequence: 7
  givenname: Yoshimi
  surname: Bando
  fullname: Bando, Yoshimi
  organization: Division of Pathology, Tokushima University Hospital
– sequence: 8
  givenname: Hiroaki
  surname: Yanagawa
  fullname: Yanagawa, Hiroaki
  organization: Clinical Trial Center for Developmental Therapeutics, Tokushima University Hospital
– sequence: 9
  givenname: Koichi
  surname: Sairyo
  fullname: Sairyo, Koichi
  organization: Department of Orthopedics, Institute of Biomedical Sciences, Tokushima University Graduate School
– sequence: 10
  givenname: Masafumi
  surname: Harada
  fullname: Harada, Masafumi
  organization: Department of Radiology, Tokushima University Hospital
BookMark eNp9kstu1TAQhiNUREvpC7CyxIZNqG-JYxZIqOJSqRIsYG05ziTxIbGD7ZSe5-SFcHoqaFl0Zfv3P5_HM_O8OHLeQVG8JPgNIU19HjlpKC8xxSXGuGHlzZPihFYEl6xm9dG9_XFxFuMum4iUspL0WXHMOJGEVOKk-P01wGRn63TYIzNZZ42ekI4RYpzBJeR71O2dnq1BRofWu5IQNEMarXfWAVp8tClkGWYbYxZR8rMfgl7G_bnx87Im6O5pqPcBpRFQZ_XgcnDcntiERafRT36wEJF129HmBCL6ZdOI5jWadfLxB0yQcoYTbG_Ft0ijJfi4gEn2GlBMa7d_UTzt9RTh7G49Lb5__PDt4nN59eXT5cX7q9LUWKSSC6g5FZS3fdtKArgFY7gQ0ErJMdM9k1I0hNctY1xjohsiagOVoKKDvmvYaXF54HZe79QS7JyLqLy26lbwYVA6JGsmUFgbJmpqoGGSdxXPizS8baGtaU9Zn1nvDqxlbWfoTP550NMD6MMbZ0c1-GvVUNIQxjLg9R0g-J8rxKRyPwxMk3bg16hoxWspKkZotr76z7rza3C5VIpRIhtBaf7_Iy7KWWZxyTYWPbhM7kIM0P9NmWC1Dao6DKrKg6puB1Xd5CB2CIrZ7AYI_9CPRP0BoQPyng
Cites_doi 10.1097/MNM.0000000000001120
10.1007/s11060-018-2834-4
10.1007/s12149-019-01350-z
10.1007/s00259-011-1865-2
10.21873/anticanres.12899
10.2967/jnumed.109.070862
10.2214/AJR.12.10261
10.1097/RLU.0b013e318262af48
10.1016/j.bbrc.2018.10.119
10.1007/s00259-010-1435-z
10.2214/AJR.16.16359
10.1097/RLU.0b013e3182443110
10.2967/jnumed.112.107466
10.1102/1470-7330.2013.0036
10.1007/s002590050276
10.1186/1477-7800-1-10
10.1102/1470-7330.2005.0007
10.1007/s00259-009-1295-6
10.2967/jnumed.112.113936
10.3109/0284186X.2012.728713
10.1007/s00330-015-4026-3
10.1038/bmt.2012.244
10.1148/radiol.11102350
10.1007/s11060-012-0873-9
10.1097/MNM.0000000000000328
10.1007/s12149-015-0990-6
10.1158/1078-0432.CCR-0190-3
10.1097/00003072-199504000-00015
10.1097/00006123-198911000-00006
ContentType Journal Article
Copyright The Author(s) 2020
The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright Springer Nature B.V. Dec 2020
Copyright_xml – notice: The Author(s) 2020
– notice: The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Copyright Springer Nature B.V. Dec 2020
DBID C6C
AAYXX
CITATION
3V.
7QO
7RV
7X7
7XB
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FR3
FYUFA
GHDGH
K9.
KB0
M0S
NAPCQ
P64
PHGZM
PHGZT
PIMPY
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s41824-020-00083-x
DatabaseName Springer Nature OA Free Journals
CrossRef
ProQuest Central (Corporate)
Biotechnology Research Abstracts
Nursing & Allied Health Database
Health & Medical Collection (ProQuest)
ProQuest Central (purchase pre-March 2016)
Technology Research Database
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials Local Electronic Collection Information
ProQuest Central (ProQuest)
ProQuest One
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals (DOAJ)
DatabaseTitle CrossRef
Publicly Available Content Database
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


Publicly Available Content Database
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2510-3636
3005-074X
EndPage 13
ExternalDocumentID oai_doaj_org_article_0ac3762ce8394d548399c4bbeb62f23f
PMC8218133
10_1186_s41824_020_00083_x
GroupedDBID 7RV
7X7
8FI
8FJ
AAFWJ
ABDBF
ABUWG
ACGFS
ACUHS
ADBBV
AFKRA
AFPKN
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
BCNDV
BENPR
C24
C6C
CCPQU
EBS
FYUFA
GROUPED_DOAJ
HMCUK
IAO
IHR
ITC
M~E
NAPCQ
PGMZT
PIMPY
PQQKQ
RPM
RSV
SOJ
UKHRP
AAYXX
CITATION
PHGZM
PHGZT
0R~
3V.
7QO
7XB
8FD
8FK
AAJSJ
AAKKN
AASML
ABEEZ
ACACY
ACULB
AFGXO
AZQEC
DWQXO
EBLON
FR3
K9.
P64
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c607t-47e642724bfbb91e0becc477eb99403af39978146b334a01a8176ce5727defd83
IEDL.DBID 7X7
ISSN 2510-3636
IngestDate Wed Aug 27 01:28:19 EDT 2025
Thu Aug 21 18:42:11 EDT 2025
Fri Sep 05 03:32:45 EDT 2025
Sat Aug 23 14:10:26 EDT 2025
Sat Aug 23 14:11:41 EDT 2025
Tue Jul 01 00:45:55 EDT 2025
Fri Feb 21 02:33:33 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords C-11 MET
Sarcoma
Diagnostic validity
SUVmax
Malignant lymphoma
Musculoskeletal lesion
Dynamic PET/CT
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c607t-47e642724bfbb91e0becc477eb99403af39978146b334a01a8176ce5727defd83
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-7101-5769
OpenAccessLink https://www.proquest.com/docview/2436974932?pq-origsite=%requestingapplication%
PMID 34191157
PQID 2436974932
PQPubID 4403478
PageCount 13
ParticipantIDs doaj_primary_oai_doaj_org_article_0ac3762ce8394d548399c4bbeb62f23f
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8218133
proquest_miscellaneous_2546975312
proquest_journals_3219872240
proquest_journals_2436974932
crossref_primary_10_1186_s41824_020_00083_x
springer_journals_10_1186_s41824_020_00083_x
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-08-26
PublicationDateYYYYMMDD 2020-08-26
PublicationDate_xml – month: 08
  year: 2020
  text: 2020-08-26
  day: 26
PublicationDecade 2020
PublicationPlace Cham
PublicationPlace_xml – name: Cham
– name: London
PublicationSubtitle EJNMMI Multimodality Journal
PublicationTitle EJNMMI reports
PublicationTitleAbbrev European J Hybrid Imaging
PublicationYear 2020
Publisher Springer International Publishing
Springer Nature B.V
SpringerOpen
Publisher_xml – name: Springer International Publishing
– name: Springer Nature B.V
– name: SpringerOpen
References Rusten, Rødal, Revheim, Skretting, Bruland, Malinen (CR30) 2013; 52
Keller, Inai, Sato, Tada, Adam, Yamamura (CR19) 2017; 208
Dimitrakopoulou-Strauss, Strauss, Heichel, Wu, Burger, Bernd (CR8) 2002; 43
van Waarde, Jager, Ishiwata, Dierckx, Elsinga (CR35) 2006; 47
Epelbaum, Frenkel, Haddad, Sikorski, Strauss, Israel (CR10) 2013; 54
Dimitrakopoulou-Strauss, Strauss, Schwarzbach, Burger, Heichel, Willeke (CR9) 2001; 42
Shinya, Otomi, Kubo, Kinoshita, Takechi, Uyama (CR33) 2019; 33
Okazumi, Dimitrakopoulou-Strauss, Schwarzbach, Straus (CR28) 2009; 12
Zhang, Yoshikawa, Tamura, Tomemori, Sagou, Tian (CR36) 2004; 10
Dimitrakopoulou-Strauss, Strauss, Egerer, Vasamiliette, Mechtersheimer, Schmitt (CR6) 2010; 51
Belakhlef, Church, Jani, Lakhanpl (CR2) 2012; 37
Inai, Shinya, Tada, Sato, Fujiwara, Takeda (CR17) 2015; 29
Higuchi, Kawaguchi, Miyake, Han, Tan, Oshiro (CR15) 2018; 38
Lapela, Leskinen-Kallio, Varpula, Grenman, Alanen, Nagren (CR22) 1994; 35
Kobayashi, Kotoura, Hosono, Sakahara, Hosono, Yao (CR20) 1995; 20
Shinya, Sato, Kunisada, Inai, Yanai, Ozaki (CR34) 2015; 36
Nomura, Asano, Shinoda, Yano, Ikegame, Kawasaki (CR25) 2018; 138
Shinya, Otomi, Dimitrakopoulou-Strauss, Kubo, Kondo, Otomo (CR32) 2020; 41
Hicks (CR14) 2005; 5
Kwee, Basu, Cheng, Alavi (CR21) 2010; 37
Nuutinen, Leskinen, Lindholm, Söderström, Någren, Huhtala (CR26) 1998; 25
Lim, Ong (CR23) 2013; 13
Fletcher, Unni, Mertens (CR12) 2002
Igarashi, Kawaguchi, Kiyuna, Miyake, Miyaki, Yamamoto (CR16) 2018; 506
Dimitrakopoulou-Strauss, Strauss, Egerer, Vasamiliette, Schmitt, Haberkorn (CR7) 2010; 37
CR5
Choong, Kunisada, Slavin, Schlicht, Hicks (CR4) 2004; 1
Schierz, Opfermann, Steenbeck, Lopatta, Settmacher, Stallmach (CR31) 2013; 54
Bernstine, Braun, Yefremov, Lamash, Carmi, Stern (CR3) 2011; 260
Kanda (CR18) 2013; 48
Fletcher, Bridge, Hogendoorn, Mertens (CR11) 2013
Fujiwara, Matsuzawa, Kubota, Abe, Itoh, Fukuda (CR13) 1989; 30
Okada, Nihashi, Fujii, Kato, Okochi, Ando (CR27) 2012; 37
Zhao, Kuge, Yi, Zhao, Hatano, Magota (CR37) 2011; 38
Aki, Nakayama, Yonezawa, Takenaka, Miwa, Asano (CR1) 2012; 109
Nakajima, Abe, Kondo, Tanabe, Sakai (CR24) 2016; 26
Raphael, Hwang, Lefkowitz, Landa, Sohn, Panicek (CR29) 2013; 201
Choong (83_CR4) 2004; 1
E Rusten (83_CR30) 2013; 52
Y Kanda (83_CR18) 2013; 48
H Zhang (83_CR36) 2004; 10
S Zhao (83_CR37) 2011; 38
Y Okada (83_CR27) 2012; 37
S Belakhlef (83_CR2) 2012; 37
R Nakajima (83_CR24) 2016; 26
K Igarashi (83_CR16) 2018; 506
B Raphael (83_CR29) 2013; 201
A Dimitrakopoulou-Strauss (83_CR7) 2010; 37
S Keller (83_CR19) 2017; 208
H Bernstine (83_CR3) 2011; 260
T Shinya (83_CR34) 2015; 36
A Dimitrakopoulou-Strauss (83_CR6) 2010; 51
Y Nomura (83_CR25) 2018; 138
T Aki (83_CR1) 2012; 109
R Epelbaum (83_CR10) 2013; 54
T Higuchi (83_CR15) 2018; 38
JH Schierz (83_CR31) 2013; 54
J Nuutinen (83_CR26) 1998; 25
A van Waarde (83_CR35) 2006; 47
A Dimitrakopoulou-Strauss (83_CR8) 2002; 43
R Inai (83_CR17) 2015; 29
T Shinya (83_CR32) 2020; 41
83_CR5
M Lapela (83_CR22) 1994; 35
H Kobayashi (83_CR20) 1995; 20
T Fujiwara (83_CR13) 1989; 30
CDM Fletcher (83_CR11) 2013
CDM Fletcher (83_CR12) 2002
A Dimitrakopoulou-Strauss (83_CR9) 2001; 42
RJ Hicks (83_CR14) 2005; 5
CY Lim (83_CR23) 2013; 13
T Shinya (83_CR33) 2019; 33
TC Kwee (83_CR21) 2010; 37
S Okazumi (83_CR28) 2009; 12
References_xml – volume: 35
  start-page: 1618
  year: 1994
  end-page: 1623
  ident: CR22
  article-title: Imaging of uterine carcinoma by carbon-11-methionine and PET
  publication-title: J Nucl Med
– volume: 41
  start-page: 26
  year: 2020
  end-page: 33
  ident: CR32
  article-title: Preliminary clinical assessment of dynamic F-fluorodeoxyglucose positron-emission tomography/computed tomography for evaluating the clinicopathological grade in patients with non-Hodgkin’s lymphoma: a prospective study
  publication-title: Nucl Med Commun
  doi: 10.1097/MNM.0000000000001120
– volume: 138
  start-page: 649
  year: 2018
  end-page: 658
  ident: CR25
  article-title: Characteristics of time-activity curves obtained from dynamic 11C-methionine PET in common primary brain tumors
  publication-title: J Neuro-Oncol
  doi: 10.1007/s11060-018-2834-4
– volume: 30
  start-page: 33
  year: 1989
  end-page: 37
  ident: CR13
  article-title: Relationship between histologic type of primary lung cancer and carbon-11-L methionine uptake with positron emission tomography
  publication-title: J Nucl Med
– volume: 42
  start-page: 713
  year: 2001
  end-page: 720
  ident: CR9
  article-title: Dynamic PET 18F-FDG studies in patients with primary and recurrent soft-tissue sarcomas: impact on diagnosis and correlation with grading
  publication-title: J Nucl Med
– volume: 33
  start-page: 414
  year: 2019
  end-page: 423
  ident: CR33
  article-title: Preliminary clinical assessment of dynamic F-fluorodeoxyglucose positron emission tomography/computed tomography for evaluating lymph node metastasis in patients with lung cancer: a prospective study
  publication-title: Ann Nucl Med
  doi: 10.1007/s12149-019-01350-z
– volume: 38
  start-page: 1876
  year: 2011
  end-page: 1886
  ident: CR37
  article-title: Dynamic 11C-methionine PET analysis has an additional value for differentiating malignant tumors from granulomas: an experimental study using small animal PET
  publication-title: Eur J Nucl Med Mol Imaging
  doi: 10.1007/s00259-011-1865-2
– year: 2013
  ident: CR11
  publication-title: WHO Classification of tumours of soft tissue and bone
– volume: 38
  start-page: 5639
  year: 2018
  end-page: 5644
  ident: CR15
  article-title: Oral recombinant methioninase combined with caffeine and doxorubicin induced regression of a doxorubicin-resistant synovial sarcoma in a PDOX mouse model
  publication-title: Anticancer Res
  doi: 10.21873/anticanres.12899
– volume: 51
  start-page: 551
  year: 2010
  end-page: 558
  ident: CR6
  article-title: Impact of dynamic 18F-FDG PET on the early prediction of therapy outcome in patients with high-risk soft-tissue sarcomas after neoadjuvant chemotherapy: a feasibility study
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.109.070862
– volume: 43
  start-page: 510
  year: 2002
  end-page: 518
  ident: CR8
  article-title: The role of quantitative (18)F-FDG PET studies for the differentiation of malignant and benign bone lesions
  publication-title: J Nucl Med
– volume: 201
  start-page: 1309
  year: 2013
  end-page: 1314
  ident: CR29
  article-title: Biopsy of suspicious bone lesions in patients with a single known malignancy: prevalence of a second malignancy
  publication-title: AJR Am J Roentgenol
  doi: 10.2214/AJR.12.10261
– volume: 37
  start-page: 843
  issue: 9
  year: 2012
  end-page: 849
  ident: CR27
  article-title: Differentiation of newly diagnosed glioblastoma multiforme and intracranial diffuse large B-cell lymphoma using (11)C-methionine and (18)F-FDG PET
  publication-title: Clin Nucl Med
  doi: 10.1097/RLU.0b013e318262af48
– volume: 12
  start-page: 223
  year: 2009
  end-page: 228
  ident: CR28
  article-title: Quantitative, dynamic 18F-FDG-PET for the evaluation of soft tissue sarcomas: relation to differential diagnosis, tumor grading and prediction of prognosis
  publication-title: Hell J Nucl Med
– volume: 506
  start-page: 912
  year: 2018
  end-page: 917
  ident: CR16
  article-title: Metabolic targeting with recombinant methioninase combined with palbociclib regresses a doxorubicin-resistant dedifferentiated liposarcoma
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2018.10.119
– volume: 37
  start-page: 1481
  year: 2010
  end-page: 1489
  ident: CR7
  article-title: Prediction of chemotherapy outcome in patients with metastatic soft tissue sarcomas based on dynamic FDG PET (dPET) and a multiparameter analysis
  publication-title: Eur J Nucl Med Mol Imaging
  doi: 10.1007/s00259-010-1435-z
– volume: 208
  start-page: 171
  year: 2017
  end-page: 179
  ident: CR19
  publication-title: AJR Am J Roentgenol
  doi: 10.2214/AJR.16.16359
– volume: 47
  start-page: 150
  year: 2006
  end-page: 154
  ident: CR35
  article-title: Comparison of sigma-ligands and metabolic PET tracers for differentiating tumor from inflammation
  publication-title: J Nucl Med
– volume: 37
  start-page: 366
  year: 2012
  end-page: 368
  ident: CR2
  article-title: Early dynamic PET/CT and F-FDG blood flow imaging in bladder cancer detection: a novel approach
  publication-title: Clin Nucl Med
  doi: 10.1097/RLU.0b013e3182443110
– volume: 54
  start-page: 12
  year: 2013
  end-page: 18
  ident: CR10
  article-title: Tumour aggressiveness and patient outcome in cancer of the pancreas assessed by dynamic F-FDG PET/CT
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.112.107466
– volume: 13
  start-page: 448
  year: 2013
  end-page: 457
  ident: CR23
  publication-title: Cancer Imaging
  doi: 10.1102/1470-7330.2013.0036
– year: 2002
  ident: CR12
  publication-title: editors. WHO classification of tumours. Pathology and genetics of tumours of soft tissue and bone
– volume: 25
  start-page: 729
  year: 1998
  end-page: 735
  ident: CR26
  article-title: Use of carbon-11 methionine positron emission tomography to assess malignancy grade and predict survival in patients with lymphoma
  publication-title: Eur J Nucl Med
  doi: 10.1007/s002590050276
– volume: 1
  start-page: 10
  year: 2004
  ident: CR4
  article-title: The role of thallium201 and pentavalent dimercaptosuccinic acid for staging cartilaginous tumours
  publication-title: Int Semin Surg Oncol
  doi: 10.1186/1477-7800-1-10
– volume: 5
  start-page: 58
  year: 2005
  end-page: 65
  ident: CR14
  article-title: Functional imaging techniques for evaluation of sarcomas
  publication-title: Cancer Imaging
  doi: 10.1102/1470-7330.2005.0007
– volume: 37
  start-page: 635
  year: 2010
  end-page: 644
  ident: CR21
  article-title: FDG PET/CT in carcinoma of unknown primary
  publication-title: Eur J Nucl Med Mol Imaging
  doi: 10.1007/s00259-009-1295-6
– volume: 54
  start-page: 848
  year: 2013
  end-page: 854
  ident: CR31
  article-title: Early dynamic F-FDG PET to detect hyperperfusion in hepatocellular carcinoma liver lesions
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.112.113936
– volume: 52
  start-page: 1160
  year: 2013
  end-page: 1167
  ident: CR30
  article-title: Quantitative dynamic FDG-PET and tracer kinetic analysis of soft tissue sarcomas
  publication-title: Acta Oncol
  doi: 10.3109/0284186X.2012.728713
– volume: 26
  start-page: 1852
  year: 2016
  end-page: 1862
  ident: CR24
  article-title: Clinical role of early dynamic FDG-PET/CT for the evaluation of renal cell carcinoma
  publication-title: Eur Radiol
  doi: 10.1007/s00330-015-4026-3
– volume: 48
  start-page: 452
  year: 2013
  end-page: 458
  ident: CR18
  article-title: Investigation of the freely available easy-to-use software 'EZR' for medical statistics
  publication-title: Bone Marrow Transplant
  doi: 10.1038/bmt.2012.244
– volume: 260
  start-page: 503
  year: 2011
  end-page: 510
  ident: CR3
  article-title: FDG PET/CT early dynamic blood flow and late standardized uptake value determination in hepatocellular carcinoma
  publication-title: Radiology
  doi: 10.1148/radiol.11102350
– volume: 109
  start-page: 115
  year: 2012
  end-page: 122
  ident: CR1
  article-title: Evaluation of brain tumors using dynamic 11C-methionine-PET
  publication-title: J Neuro-Oncol
  doi: 10.1007/s11060-012-0873-9
– volume: 36
  start-page: 802
  year: 2015
  end-page: 807
  ident: CR34
  article-title: Both a visual and a semiquantitative analysis for differentiating benign from malignant chondrogenic bone tumors using Tc-99 m (V) DMSA scintigraphy: a prospective study
  publication-title: Nucl Med Commun
  doi: 10.1097/MNM.0000000000000328
– ident: CR5
– volume: 29
  start-page: 674
  year: 2015
  end-page: 681
  ident: CR17
  article-title: Diagnostic value of Thallium-201 scintigraphy in differentiating malignant bone tumors from benign bone lesions
  publication-title: Ann Nucl Med
  doi: 10.1007/s12149-015-0990-6
– volume: 10
  start-page: 1764
  issue: 5
  year: 2004
  end-page: 1772
  ident: CR36
  article-title: [(11)C]methionine positron emission tomography and survival in patients with bone and soft tissue sarcomas treated by carbon ion radiotherapy
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-0190-3
– volume: 20
  start-page: 361
  year: 1995
  end-page: 364
  ident: CR20
  article-title: Diagnostic value of Tc-99 m (V) DMSA for chondrogenic tumors with positive Tc-99 m HMDP uptake on bone scintigraphy
  publication-title: Clin Nucl Med
  doi: 10.1097/00003072-199504000-00015
– volume: 260
  start-page: 503
  year: 2011
  ident: 83_CR3
  publication-title: Radiology
  doi: 10.1148/radiol.11102350
– volume: 37
  start-page: 366
  year: 2012
  ident: 83_CR2
  publication-title: Clin Nucl Med
  doi: 10.1097/RLU.0b013e3182443110
– volume: 48
  start-page: 452
  year: 2013
  ident: 83_CR18
  publication-title: Bone Marrow Transplant
  doi: 10.1038/bmt.2012.244
– volume: 37
  start-page: 635
  year: 2010
  ident: 83_CR21
  publication-title: Eur J Nucl Med Mol Imaging
  doi: 10.1007/s00259-009-1295-6
– volume: 43
  start-page: 510
  year: 2002
  ident: 83_CR8
  publication-title: J Nucl Med
– volume: 36
  start-page: 802
  year: 2015
  ident: 83_CR34
  publication-title: Nucl Med Commun
  doi: 10.1097/MNM.0000000000000328
– volume: 37
  start-page: 1481
  year: 2010
  ident: 83_CR7
  publication-title: Eur J Nucl Med Mol Imaging
  doi: 10.1007/s00259-010-1435-z
– volume: 29
  start-page: 674
  year: 2015
  ident: 83_CR17
  publication-title: Ann Nucl Med
  doi: 10.1007/s12149-015-0990-6
– volume: 201
  start-page: 1309
  year: 2013
  ident: 83_CR29
  publication-title: AJR Am J Roentgenol
  doi: 10.2214/AJR.12.10261
– volume: 35
  start-page: 1618
  year: 1994
  ident: 83_CR22
  publication-title: J Nucl Med
– volume: 30
  start-page: 33
  year: 1989
  ident: 83_CR13
  publication-title: J Nucl Med
– volume: 41
  start-page: 26
  year: 2020
  ident: 83_CR32
  publication-title: Nucl Med Commun
  doi: 10.1097/MNM.0000000000001120
– volume-title: editors. WHO classification of tumours. Pathology and genetics of tumours of soft tissue and bone
  year: 2002
  ident: 83_CR12
– volume: 109
  start-page: 115
  year: 2012
  ident: 83_CR1
  publication-title: J Neuro-Oncol
  doi: 10.1007/s11060-012-0873-9
– volume: 37
  start-page: 843
  issue: 9
  year: 2012
  ident: 83_CR27
  publication-title: Clin Nucl Med
  doi: 10.1097/RLU.0b013e318262af48
– volume: 38
  start-page: 1876
  year: 2011
  ident: 83_CR37
  publication-title: Eur J Nucl Med Mol Imaging
  doi: 10.1007/s00259-011-1865-2
– volume: 47
  start-page: 150
  year: 2006
  ident: 83_CR35
  publication-title: J Nucl Med
– volume: 25
  start-page: 729
  year: 1998
  ident: 83_CR26
  publication-title: Eur J Nucl Med
  doi: 10.1007/s002590050276
– volume: 208
  start-page: 171
  year: 2017
  ident: 83_CR19
  publication-title: AJR Am J Roentgenol
  doi: 10.2214/AJR.16.16359
– volume: 506
  start-page: 912
  year: 2018
  ident: 83_CR16
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2018.10.119
– volume: 54
  start-page: 848
  year: 2013
  ident: 83_CR31
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.112.113936
– volume: 26
  start-page: 1852
  year: 2016
  ident: 83_CR24
  publication-title: Eur Radiol
  doi: 10.1007/s00330-015-4026-3
– ident: 83_CR5
  doi: 10.1097/00006123-198911000-00006
– volume: 54
  start-page: 12
  year: 2013
  ident: 83_CR10
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.112.107466
– volume: 1
  start-page: 10
  year: 2004
  ident: 83_CR4
  publication-title: Int Semin Surg Oncol
  doi: 10.1186/1477-7800-1-10
– volume: 52
  start-page: 1160
  year: 2013
  ident: 83_CR30
  publication-title: Acta Oncol
  doi: 10.3109/0284186X.2012.728713
– volume: 10
  start-page: 1764
  issue: 5
  year: 2004
  ident: 83_CR36
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-0190-3
– volume: 13
  start-page: 448
  year: 2013
  ident: 83_CR23
  publication-title: Cancer Imaging
  doi: 10.1102/1470-7330.2013.0036
– volume: 12
  start-page: 223
  year: 2009
  ident: 83_CR28
  publication-title: Hell J Nucl Med
– volume: 33
  start-page: 414
  year: 2019
  ident: 83_CR33
  publication-title: Ann Nucl Med
  doi: 10.1007/s12149-019-01350-z
– volume: 38
  start-page: 5639
  year: 2018
  ident: 83_CR15
  publication-title: Anticancer Res
  doi: 10.21873/anticanres.12899
– volume: 20
  start-page: 361
  year: 1995
  ident: 83_CR20
  publication-title: Clin Nucl Med
  doi: 10.1097/00003072-199504000-00015
– volume-title: WHO Classification of tumours of soft tissue and bone
  year: 2013
  ident: 83_CR11
– volume: 5
  start-page: 58
  year: 2005
  ident: 83_CR14
  publication-title: Cancer Imaging
  doi: 10.1102/1470-7330.2005.0007
– volume: 51
  start-page: 551
  year: 2010
  ident: 83_CR6
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.109.070862
– volume: 42
  start-page: 713
  year: 2001
  ident: 83_CR9
  publication-title: J Nucl Med
– volume: 138
  start-page: 649
  year: 2018
  ident: 83_CR25
  publication-title: J Neuro-Oncol
  doi: 10.1007/s11060-018-2834-4
SSID ssj0001999592
ssj0003307236
Score 2.1174247
Snippet Background This study prospectively assessed the diagnostic capacity of dynamic carbon-11 methionine (C-11 MET) positron-emission tomography (PET)/computed...
BackgroundThis study prospectively assessed the diagnostic capacity of dynamic carbon-11 methionine (C-11 MET) positron-emission tomography (PET)/computed...
This study prospectively assessed the diagnostic capacity of dynamic carbon-11 methionine (C-11 MET) positron-emission tomography (PET)/computed tomography for...
Abstract Background This study prospectively assessed the diagnostic capacity of dynamic carbon-11 methionine (C-11 MET) positron-emission tomography...
SourceID doaj
pubmedcentral
proquest
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 15
SubjectTerms C-11 MET
Carbon
Computed tomography
Diagnosis
Diagnostic systems
Diagnostic validity
Dynamic PET/CT
Emission analysis
Imaging
Lesions
Lymphoma
Malignant lymphoma
Medical diagnosis
Medicine
Medicine & Public Health
Metastases
Methionine
Musculoskeletal lesion
Nuclear Medicine
Original
Original Article
Phases
Positron emission
Positron emission tomography
Radiology
Sarcoma
Tomography
Tumors
SummonAdditionalLinks – databaseName: Directory of Open Access Journals (DOAJ)
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Pi9UwEA6yB_Ei_sSnq4zgTctLkzRtvam4LILiwYW9hSRN8OFuK-17sP6d_kPOpO3zdVG8eCtJaUpmknwzmfmGsRe2CmUeizrDB5-pIvCsruom48JHVXHteUzRFp_06Zn6cF6cH5T6opiwkR54nLg1tx7XgPABT3LVIL7GE9Ur54LTIgoZafflNT8wppJ3pSYeLTFnyVR6PShE0iojaynhjuxqcRIlwv4FyrweI3ntojSdPyd32O0JOMKb8Yfvshuhvcdufpyuxu-zn5_7cJFKdPU_YM53BLsn3oQuQjOWnwdve9e1WZ4DFZBOHtkAKXyrx2aqAEc-NNh2lxOh9dqPxR-agzZAuAsIH6EZo_U2Aw1BDVTlOO2pYYBNCxN16wDk84XLHYW-dsM3PO8Q-MNFoLGG12ABZ2VO_IREe_uAnZ28__LuNJsqNmRe83KbqTKgPVMK5aJzdR44aYgqy-DqWnFpIwqPOLa0k1JZntsqL7UPBYKoJsSmkg_ZUdu14RGDQnhdyaibyqPNJ6SrG4vyLhvK1NVWr9jLWXrm-0jMYZJBU2kzytqgrE2Stblasbck4P2bRKqdGlDVzKRq5l-qtmLHs3qYaaUPRiip0SZDGPzHbinIq0O4acWe77tRjnQvY9vQ7fAThdKU35zjJ8qF1i3-d9nTbr4mMvCKMJqUK_Zq1s_fg_99Ph7_j_l4wm6JtJ5wr9XH7Gjb78JThGhb9yytxl8m7z_L
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3Na9VAEF-kgniR-oVPq4zgTZcmu5tN4k2LpQiKBwu9hf3Eh20iyXtg_07_IWc2yWtT6sFb2E2yITO7-5vZmd8w9sZUocxjUXO8cFwVIeN1VXueCRdVlWmXxRRt8VWfnKrPZ8XZRJNDuTDXz-_zSh8OCgGw4mTkJLjAES_eLXKp08GsPrryp9TEnCXmvJhbH13sPYmif4Erb0ZF3jgaTTvO8T57MEFF-DDK9iG7E9pH7N6X6TD8MfvzrQ_nqShXfwlzhiOYHdUmdBH8WHAenOlt1_I8ByoZnXywAVLAVo_NVPONvGaw6S4mCutDN5Z78NfaAAEuIGAEP8bnrQcaghqornFaRcMA6xYmstYByMsLF1sKdu2Gn7jDIdSH80BjDe_BAP6VOdUTEtHtE3Z6_On70QmfajRwp7Nyw1UZ0IIphbLR2joPGemEKstg61pl0kQEQMSqpa2UymS5qfJSu1AgbPIh-ko-ZXtt14ZnDArhdCWj9pVDK09IW3sThSw95eZqo1fs7Sy95tdIxdEkE6bSzSjrBmXdJFk3v1fsIwl4dyfRaKcG1K5mmpVNZhwusMIFhInKo_GGX-uUtcFqgUPHFTuY1aOZ5vbQCCU1WmEIfG_tloL8OISUVuz1rhvlSCcxpg3dFl9RKE0ZzTm-olxo3eJ7lz3t-kei_64IlUm5Yu9m_bwa_N__4_n_3f6C3Rdp5uA6qg_Y3qbfhpcIvzb2VZp3fwEkITBx
  priority: 102
  providerName: Springer Nature
Title Preliminary clinical assessment of dynamic carbon-11 methionine positron-emission tomography/computed tomography for the diagnosis of the pathologies in patients with musculoskeletal lesions: a prospective study
URI https://link.springer.com/article/10.1186/s41824-020-00083-x
https://www.proquest.com/docview/2436974932
https://www.proquest.com/docview/3219872240
https://www.proquest.com/docview/2546975312
https://pubmed.ncbi.nlm.nih.gov/PMC8218133
https://doaj.org/article/0ac3762ce8394d548399c4bbeb62f23f
Volume 4
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgkxAviE9RGJWReAOrie3YCS-oqzZNlZgmYFLfIsd2oGJLRtJK4-_kH-LOSToyAU-JzlWc5s7n353vg5A3JvU6LpOMwY1lMvERy9LMsYjbUqaRslEZoi1O1cm5XK6SVe9wa_uwykEnBkXtaos-8hmXQgH2Bbjx4eoHw65ReLrat9C4S_ZD6TKQZ73SOx8L2Oqa4-lklyuTqlkrAU9LhjZTQB_serQfhbL9I6x5O1Ly1nFp2IWOH5IHPXyk847fj8gdXz0m9z72B-RPyK-zxl-ERl3NTzpkPVKzK79J65K6rgk9taYp6orFMcU20sEv62kI4mqAjH3g0JNGN_VlX9Z6ZrsWEO4PGgXQSwFEUtfF7K1bnAIJ2Os4aFbf0nVF-wKuLUXPL73cYgBs3X6HXQ_gP73wOFf7nhoKX2VI_6Sh-O1Tcn589GVxwvq-DcyqSG-Y1B6sGs1lURZFFvsI5URq7Yssk5EwJYAirLSlCiGkiWKTxlpZnwCUcr50qXhG9qq68s8JTbhVqSiVSy1YflwUmTMlF9phvq4yakLeDtzLr7ryHHkwa1KVd7zOgdd54HV-PSGHyODdL7G0diDUzde8X6l5ZCwoXW49QEfpwKCDt7WyKHyhOExdTsjBIB55v97b_EY6_zosOPp2ED1NyOvdMPART2dM5estPCKRCrOcY3iEHknd6H3HI9X6WygJniJSE2JC3g3yeTP5v7_Hi___lZfkPg8rBXSpOiB7m2brXwEE2xTTsM6mZH8-X35ewvXw6PTsE1AXajENbo1p8Jv9BsHlPSM
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELdGJwEviL-iMMBI8ARWE9txEiSEGGzq2FZNaJP25sWOAxVbMpJWbF-KL8MX4s5JOjoBb3ur7MpOcr67353vDyEvssTFYRGlDH5YJiMXsDRJcxZwW8gkUDYofLTFRI0P5KfD6HCF_OxzYTCsspeJXlDnlUUf-YhLoQD7Atx4d_qdYdcovF3tW2i0x2Lbnf8Ak615u_UR6PuS882N_Q9j1nUVYFYF8YzJ2AHmjrk0hTFp6AJ8CxnHzqSpDERWgMrGOlDKCCGzIMySMFbWRaDoc1fkiYB1r5FViRmtA7K6vjHZ-7zw6ghgGY73oW12TqJGjQQELxlaaR7vsLMlDegbBSyh28uxmZcuaL3e27xNbnWAlb5vT9gdsuLKu-T6bnclf4_82qvdsW8NVp_TPs-SZouCn7QqaN62vac2q01VsjCk2Ljae4Id9WFjNQxj5zn03dFZddIV0h7ZtulE_scYBZhNAbbSvI0SnDa4BQ5gd2Uvy11DpyXtSsY2FH3N9GSOIbdV8w30LBgc9NjhXs0bmlH4Kn3CKfXldu-Tgyuh6QMyKKvSPSQ04lYlolB5YsHW5MKkeVZwEeeYIawyNSSveurp07YgiPaGVKJ0S2sNtNae1vpsSNaRwIt_YjFvP1DVX3QnG3SQWRDz3DoAqzIHExKe1kpjnFEcti6GZK0_HrqTMI2-4Ie_TguO3iTEa0PyfDENdMT7oKx01RyWiKTCvOoQloiXTt3S8y7PlNOvvgh5gthQiCF53Z_Pi83__T0e_f9VnpEb4_3dHb2zNdl-TG5yzzUgydUaGczquXsCAHBmnnZcR8nRVTP6b0NIdPQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Jb9QwFLZQkSouiFUMFDASN4gmsR0n4QaFUdmqHqjUm-UVRrRJlWQk-J38Id5zkmlTlQO3yE7iKM_L97bvEfJSl77IQl4lcGETkfs0qcrKJSmzQZSptGmI0RaH8uBYfDrJTy5l8cdo98klOeQ0IEtT3S_PXRiWeCmXnQBYLBJUfSKISABF3hR49KG7Vu5fWFkq5NNiU7bMtY_OTqRI3D9Dm1djJa84TOM5tLpDbo8Akr4dJH6X3PD1PbL7dXSR3yd_jlp_Gkt1tb_plPdI9ZaAkzaBuqEMPbW6NU2dZBnFQtLRMutpDONqoRkrwaEtjfbN2UhsvbRDEQh3qY0C7KUAI6kbovbWHQ6BDVjtOO6tvqPrmo4Urh1F2y8922AIbNP9hHMPFAB66nGs7g3VFP7KlABKI_3tA3K8-vBt_yAZKzckVqZFn4jCg15TMGGCMVXmU5wpoii8qSqRch0AFiHXljScC51muswKaX0OYMr54Er-kOzUTe0fEZozK0sepCst6H6Mm8rpwHjhMGNXarkgrybpqfOBoENFxaaUapC1AlmrKGv1a0HeoYC3dyK5dmxo2u9qXKsq1Ra2XWY9gEfhQKWDr7XCGG8kg6HDguxN00ONK75TTHAJuhnA4Wu7OUPrDuKnBXmx7QY5on9G177ZwCtyITHPOYNXFLNZN_veeU-9_hFJwUvEapwvyOtpfl4M_u__8fj_bn9Odo_er9SXj4efn5BbLC4i2GjlHtnp241_CvisN8_iEvwLDf47pQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Preliminary+clinical+assessment+of+dynamic+carbon-11+methionine+positron-emission+tomography%2Fcomputed+tomography+for+the+diagnosis+of+the+pathologies+in+patients+with+musculoskeletal+lesions%3A+a+prospective+study&rft.jtitle=EJNMMI+reports&rft.au=Takayoshi%2C+Shinya&rft.au=Otomi+Yoichi&rft.au=Nishisho+Toshihiko&rft.au=Beuthien-Baumann+Bettina&rft.date=2020-08-26&rft.pub=Springer+Nature+B.V&rft.eissn=3005-074X&rft.volume=4&rft.issue=1&rft_id=info:doi/10.1186%2Fs41824-020-00083-x
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2510-3636&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2510-3636&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2510-3636&client=summon